Khrom Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Sell
647,006
-4,547,619
-88% -$117M 1.6% 13
2026
Q1
$122M Sell
5,194,625
-2,156,409
-29% -$39M 11.11% 2
2025
Q4
$104M Buy
7,351,034
+2,313,586
+46% +$43.8M 10.84% 3
2025
Q3
$125M Buy
5,037,448
+2,556,469
+103% +$57M 12.96% 3
2025
Q2
$56.3M Buy
2,480,979
+893,680
+56% +$21.2M 6.27% 7
2025
Q1
$48.1M Buy
1,587,299
+336,297
+27% +$12.8M 6.43% 7
2024
Q4
$49.6M Buy
+1,251,002
New +$56.4M 5.62% 9

Other funds holding ACHC

Khrom Capital Management's ACHC Position: Q2 2026 in Review

Khrom Capital Management reduced its Acadia Healthcare (ACHC) stake by 88% in Q2 2026, selling an estimated $117M and leaving 647,006 shares worth $19.1M. The position accounts for 1.6% of the portfolio, ranked #13.

Khrom Capital Management first reported a position in ACHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $125M in Q3 2025. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Khrom Capital Management held 647,006 shares of Acadia Healthcare worth $19.1M as of Q2 2026.
  • Khrom Capital Management sold 4,547,619 Acadia Healthcare shares in Q2 2026, an estimated $117M.
  • Acadia Healthcare made up 1.6% of Khrom Capital Management's portfolio in Q2 2026, its #13 holding.
  • Khrom Capital Management first reported a position in Acadia Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Khrom Capital Management's Acadia Healthcare position peaked at $125M in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Khrom Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.